Asia-Pacific Immunoprotein Testing Market, 2019-2023: A 17-Country Analysis--Supplier Shares, Segment Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities
This new report from LeadingMarketResearch.com presents analysis of the immunoprotein testing market in 17 countries, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
The report provides test volume and sales forecasts by country and market segment for the following assays:
This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by country, market segment and individual test; reviews leading analyzers; and profiles key competitors.
Contains 260 pages and 57 tables
Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
The report provides test volume and sales forecasts by country and market segment for the following assays:
- C3
- C4
- Ceruloplasmin
- Free Light Chains
- Haptoglobin
- IgA
- IgE Specific
- IgE Total
- IgG
- IgM
- Immunofixation
- Prealbumin
- Protein Electrophoresis
This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by country, market segment and individual test; reviews leading analyzers; and profiles key competitors.
Contains 260 pages and 57 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Ceruloplasmin
3. Free Light Chains
4. Immunofixation
5. Immunoglobulins (IgA, IgE, IgG, IgM)
6. Haptoglobin
7. Prealbumin
8. Protein Electrophoresis
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
COUNTRY ANALYSES
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Ceruloplasmin
3. Free Light Chains
4. Immunofixation
5. Immunoglobulins (IgA, IgE, IgG, IgM)
6. Haptoglobin
7. Prealbumin
8. Protein Electrophoresis
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
COUNTRY ANALYSES
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako